Keyphrases
Age-standardized Rate
14%
Confidence Interval
57%
Conscripts
14%
Cutaneous Human Papillomavirus
14%
Denmark
100%
Disease Burden
14%
Epidemiology
14%
Genital Human Papillomavirus
14%
High Risk
14%
High-risk Human Papillomavirus (HR-HPV)
100%
HPV16
28%
Human Papillomavirus 6
14%
Human Papillomavirus Prevalence
28%
Human Papillomavirus Testing
100%
Human Papillomavirus Types
14%
Hybrid Capture
71%
Infection Rate
14%
LipA
14%
Low-risk Human Papillomavirus
14%
Male Population
14%
Natural History
14%
Papillomavirus Infections
100%
Polymerase Chain Reaction
28%
Polymerase Chain Reaction Assay
14%
Population-based Cross-sectional Study
14%
Positive Samples
14%
Swab Samples
14%
Testing Method
100%
Medicine and Dentistry
Cohort Effect
11%
Disease Burden
11%
Human Papillomavirus Related Disease
11%
Human Papillomavirus Type 16
22%
Human Papillomavirus Type 51
22%
Human Papillomavirus Type 6
11%
Papillomavirus Infection
100%
Polymerase Chain Reaction
33%
Population
11%
Prevalence
100%
Wart Virus
100%
Biochemistry, Genetics and Molecular Biology
Disease Burden
7%
Human Papillomavirus Type 16
14%
Human Papillomavirus Type 51
14%
Human Papillomavirus Type 6
7%
Polymerase Chain Reaction
21%
Population
7%
Prevalence
100%
Wart Virus
100%
Neuroscience
Human Papillomavirus
100%
Polymerase Chain Reaction
15%
Pharmacology, Toxicology and Pharmaceutical Science
Human Papillomavirus Type 51
20%